期刊文献+

孟鲁司特钠片体外溶出度方法的建立 被引量:4

Establishment of Dissolution Test of Montelukast Sodium Tablet in Vitro
原文传递
导出
摘要 目的:建立孟鲁司特钠片溶出度测定方法。方法:采用桨法,以0.2%十二烷基硫酸钠-水为溶出介质,转速为50r·min-1;采用高效液相色谱法测定孟鲁司特钠的浓度并计算溶出度,色谱柱为Ultimate Phenyl,流动相为水-乙腈-三氟乙酸(200∶800∶2),检测波长为389nm。结果:孟鲁司特钠检测浓度线性范围为0.04~0.32mg·mL-1(r=0.9999),低、中、高浓度平均回收率分别为99.39%、99.84%、100.41%(RSD为1.23%、1.51%、0.83%);3批样品在30min时溶出度均在80%以上。结论:本方法准确、可靠,可用于该制剂溶出度的测定。 OBJECTIVE: To establish a method for the dissolution determination of Montelukast sodium tablets. METHODS: The paddle method was adopted with 0.2% sodium lauryl sulfate-water as solvent at rotation speed of 50 r. min^-1. The dissolution rates of montelukast sodium were determined by HPLC with detection wavelength set at 389 nm. Mobile phase consisted of water-acetonitrile-trifluoroacetic acid (200:800:2). RESULTS: Montelukast sodium showed a good linear relationship within the range of 0.04-0.32 mg.mL^-1 (r=0.999 9); the average recovery rates of low, medium and high concentrations of montelukast sodium were 99.39%, 99.84% and 100.41% (RSD=l.23%, 1.51% ,0.83%); the dissolution rate of 3 batches of samples were all above 80 % at 30 min. CONCLUSION: The method is accurate, reliable and applicable for the dissolution determination of Moutelukast sodium tablet.
出处 《中国药房》 CAS CSCD 北大核心 2011年第13期1213-1215,共3页 China Pharmacy
关键词 孟鲁司特片 溶出度 桨法 高效液相色谱法 Montelukast sodium tablet Dissolution rate Paddle method HPLC
  • 相关文献

参考文献6

  • 1刘莹.顺尔宁[J].中国新药杂志,2001,10(2):136-137. 被引量:71
  • 2Reiss TF, Chervinsky P, Dockhorn R J, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial[J]. Arch Intern Med, 1998, 158 (11) : 1 213.
  • 3Lee MY, Lai YS, Yang KD, et al. Effects of montelukast on symptoms and eNO in children with mild to moderate asthma[J]. Pediatr lnt, 2005,47 (6) : 622.
  • 4国家药典委员会编冲华人民共和国药典(二部)[S].2005年版.北京:化学工业出版社,2005:附录ⅣA、XC.
  • 5Thibert R, Mach H, Clas SD, et al. Characterization of the self-association properties of a leukotriene D4 recep- tor antagonist, MK-0476[J]. Int J Pharm, 1996, 134 (1-2):59.
  • 6谢沐风.简介日本“药品品质再评价”工程(溶出度研究系列一)[J].中国药品标准,2005,6(6):42-46. 被引量:133

共引文献204

同被引文献31

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部